Pulmonx Corp. (NASDAQ:LUNG) is a top stock under $3 to invest in with a lowered price target to $4 from $8 by Lake Street. Wall Street views the return of former executives positively, making the shares attractive due to clinical proof of concept and market opportunity.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing